FDA Approved: DIFICID — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved DIFICID (fidaxomicin) under an original application from Merck Sharp & Dohme LLC for the treatment of Clostridioides difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Dificid (fidaxomicin)

Snippet

ORIG AP for DIFICID (FIDAXOMICIN)